English
  • Dabrafenib

    Dabrafenib

    API nomi Ko'rsatma Innovator Patentning amal qilish muddati (AQSh)
    Dabrafenib      
    so'rovtafsilot
  • Aprocitentan

    Aprocitentan

    API nomi Ko'rsatma Innovator Patentning amal qilish muddati (AQSh)
    Aprocitentan      
    so'rovtafsilot
  • Etrasimod

    Etrasimod

    API nomi Ko'rsatma Innovator Patentning amal qilish muddati (AQSh)
    Etrasimod Yarali kolit (UC) Arena (Pfizer) 2030 yil 05 mart
    so'rovtafsilot
  • Tirzepatid

    Tirzepatid

    API nomi Ko'rsatma Innovator Patentning amal qilish muddati (AQSh)
    Tirzepatid 2-toifa diabet, vazn yo'qotish Eli Lilli 2036 yil 05 yanvar
    so'rovtafsilot
  • Semaglutid

    Semaglutid

    API nomi Ko'rsatma Innovator Patentning amal qilish muddati (AQSh)
    Semaglutid 2-toifa diabet, vazn yo'qotish Yangi Nordisk 2031 yil 05 dekabr
    so'rovtafsilot
  • Otesekonazol

    Otesekonazol

    API nomi Ko'rsatma Innovator Patentning amal qilish muddati (AQSh)
    Otesekonazol Kasallikning chastotasini kamaytiring

    takroriy vulvovaginal kandidoz

    		 MycoviaPharmaceuticals 2031 yil 22 aprel
    so'rovtafsilot
  • Finerenon

    Finerenon

    API nomi Ko'rsatma Innovator Patentning amal qilish muddati (AQSh)
    Finerenon Diabetik nefropatiya Bayer 2029 yil 12 aprel
    so'rovtafsilot
  • Vibegron

    Vibegron

    API nomi Ko'rsatma Innovator Patentning amal qilish muddati (AQSh)
    Vibegron OAB Urovant 2030 yil 01 dekabr
    so'rovtafsilot
  • Capivasertib

    Capivasertib

    API nomi Ko'rsatma Innovator Patentning amal qilish muddati (AQSh)
    Capivasertib ko'krak saratoni AstraZeneca 10.03.2030
    so'rovtafsilot
  • Resmetirom

    Resmetirom

    API nomi Ko'rsatma Innovator Patentning amal qilish muddati (AQSh)
    Resmetirom NASH Roche 2026 yil 12 sentyabr
    so'rovtafsilot
  • Darolutamid

    Darolutamid

    API nomi Ko'rsatma Innovator Patentning amal qilish muddati (AQSh)
    Darolutamid prostata saratonini davolash Bayer 2033 yil 25 mart
    so'rovtafsilot
  • Upadacitinib

    Upadacitinib

    API nomi Ko'rsatma Innovator Patentning amal qilish muddati (AQSh)
    Upadacitinib Atopik dermatit ABBVIE INC 2030 yil 01 dekabr
    so'rovtafsilot
123456Keyingi >>> 1/6-sahifa